Ted Monohon - Dec 5, 2022 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Chief Accounting Officer & VP
Signature
/s/ Ted Monohon
Stock symbol
QNCX
Transactions as of
Dec 5, 2022
Transactions value $
-$1,181
Form type
4
Date filed
12/7/2022, 04:37 PM
Previous filing
Sep 8, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Tax liability -$1.18K -1.64K -5.3% $0.72 29.3K Dec 5, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022.